Myriad Publishes Data on HRD Test to Detect Response to Platinum-Based Therapy, PARP Inhibitors | GenomeWeb

Myriad Publishes Data on HRD Test to Detect Response to Platinum-Based Therapy, PARP Inhibitors | GenomeWeb

 Researchers from Myriad Genetics, the Royal College of Surgeons, and elsewhere have published data showing that the company's homologous recombination deficiency assay can gauge whether ovarian tumor cells have impaired ability to repair DNA function that cancer cells need to survive.....